Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Details Narrative)

v3.7.0.1
Fair Value Measurements (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Dec. 31, 2016
Business combination, contingent consideration liabilities $ 235 $ 260
RedPath Integrated Pathology, Inc [Member] | Termination Agreement [Member]    
Business combination, contingent consideration liabilities 6,000  
Business combination, operating expenses $ 5,800